Measured Wealth Private Client Group, LLC Abb Vie Inc. Transaction History
Measured Wealth Private Client Group, LLC
- $296 Million
- Q3 2024
A detailed history of Measured Wealth Private Client Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Measured Wealth Private Client Group, LLC holds 3,249 shares of ABBV stock, worth $554,506. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,249
Previous 4,410
26.33%
Holding current value
$554,506
Previous $756,000
15.21%
% of portfolio
0.22%
Previous 0.27%
Shares
25 transactions
Others Institutions Holding ABBV
# of Institutions
3,869Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$29.3 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.5 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$8.93 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.61 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $302B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...